TNFSF13 and myeloid sarcoma: Overall, the clinical observations from the atacicept clinical trial and the experimental data from MS patients and EAE mice demonstrate that BAFF and APRIL play a critical role in maintaining a healthy balance of inflammatory and anti-inflammatory B cells and positively impact the disease outcome of MS patients.